LATEST
No need for Hong Kong to match Singapore’s HK$400,000 birth perk, top official says✦BB Telugu: Incoming Wild Cards?✦Sri Lanka trial for 2019 Easter Sunday bombings set to finish✦Karnataka Unanimous Against Kasturirangan Report: Congress' Ponnanna✦Chiranjeevi Responds to Allegations Over His Blood Bank✦
Tue, Sep 22, 2026
Loading weather...
Markets

AbbVie Secures EU Approval For RINVOQ In Children With Juvenile Arthritis

(RTTNews) - AbbVie (ABBV) announced that the European Commission has approved RINVOQ for the treatment of active polyart...

By Dhallo News · September 22, 2026 at 1:45 PM IST

(RTTNews) - AbbVie (ABBV) announced that the European Commission has approved RINVOQ for the treatment of active polyarticular juvenile idiopathic arthritis in children aged two years and older who have responded inadequately to, or are intolerant of, one or more disease-modifyin

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

'Tata Group Must Be Protected': Sharad Pawar weighs in on Tata Sons-Tata Trusts row

A dispute has emerged between Tata Sons and Tata Trusts following N Chandrasekar...

Read Article »

Glass Wall Systems share price hits record high, up 75% from IPO price | Why is the stock rallying?

Glass Wall Systems (India) Ltd shares surged over 7% to a record ₹318, represent...

Read Article »

Uber Freight Plans To Expand Its European Fourth-Party Logistics Business

(RTTNews) - Uber Technologies, Inc. (UBER), the ride hailing app, Tuesday announ...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.